CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Aclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates

EarningsNeutral
AI Analysis

Summary

Aclaris Therapeutics reported Q2 2026 results with a net loss but topped revenue estimates.

Financial Highlights

Revenue

beat estimates

Importance:2/10
Sentiment:
0.00
earningsQ2revenue
Related Companies

Read the original article

Published by yahoo_finance on August 6, 2026 12:20 PM

Read Original